Compare TVTX & HWKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TVTX | HWKN |
|---|---|---|
| Founded | N/A | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.0B |
| IPO Year | 2013 | 1995 |
| Metric | TVTX | HWKN |
|---|---|---|
| Price | $28.06 | $149.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 2 |
| Target Price | $36.85 | ★ $200.00 |
| AVG Volume (30 Days) | ★ 1.3M | 98.7K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.50% |
| EPS Growth | ★ 92.89 | 12.26 |
| EPS | N/A | ★ 3.17 |
| Revenue | N/A | ★ $974,431,000.00 |
| Revenue This Year | $44.75 | $12.37 |
| Revenue Next Year | $26.82 | $6.30 |
| P/E Ratio | ★ N/A | $47.71 |
| Revenue Growth | N/A | ★ 6.01 |
| 52 Week Low | $12.91 | $100.35 |
| 52 Week High | $42.13 | $186.15 |
| Indicator | TVTX | HWKN |
|---|---|---|
| Relative Strength Index (RSI) | 40.24 | 57.70 |
| Support Level | $27.01 | $150.01 |
| Resistance Level | $31.47 | $151.83 |
| Average True Range (ATR) | 1.64 | 5.24 |
| MACD | -0.02 | 0.87 |
| Stochastic Oscillator | 25.89 | 75.30 |
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.